Navigation Links
FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer

EVERETT, Wash., Feb. 14, 2013 /PRNewswire/ -- The United States Food and Drug Administration (FDA) announced today it has granted the new automated, multifunctional ESA615 Electrical Safety Analyzer 510(k) clearance. Now medical device quality and safety professionals can test to the newest safety standards in just minutes using this all-in-one automated test tool.



The ESA615 offers built-in standardized test sequences so every test is executed quickly and accurately with clear pass/fail indication of test results. It tests to the new IEC62353 (VDE751), IEC60601-1 (2nd and 3rd editions), ANSI/AAMI ES-1, NFPA-99, and AS/NZS 3551 standards. Not only does it test to the newest global standards, customers can interface in English, French, German, Spanish, Italian or Portuguese.

With built-in automation, there is no need to carry a laptop for complete automated testing and documentation of electrical safety tests. Quick data entry and error-free reporting reduce test time and improve quality of test results making data management easy.

"The ESA615 brings built-in automated testing to the palm of your hand," explains Shirin Khanna , Product Marketing Manager for Fluke Biomedical. "ESA615 provides exceptional value by getting the job done accurately, faster, easier, and with better technology than ever before."

For more information on the new ESA615 Electrical Safety Analyzer, global electrical safety standards, product demonstration/training materials, and the entire line of Fluke Biomedical electrical safety testers, visit

About Fluke Biomedical
Fluke Biomedical is the premiere, global provider of test and measurement equipment and services to the healthcare industry. We strive to be the best at delivering innovative solutions to improve quality of global health. We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals. For more information on Fluke Biomedical, visit

For More Information
Shannon Deveny
Marketing Communications Manager
(425) 446-6064

SOURCE Fluke Biomedical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
(Date:12/1/2015)... 2015 Assurex Health, Inc. today announced ... healthcare providers an expanded range of options in ... from depression, anxiety, bipolar disorder, posttraumatic stress disorder ... i .   --> ... addition of two new drug classes, 17 FDA-approved ...
(Date:12/1/2015)... 2015 --> ... "Nucleic Acid Labeling Market by Product (Reagents & Kits, ... In Vitro Transcription, Reverse Transcription, End Labeling), by Region ... global market is expected to reach USD 1,925.7 Million ... at a CAGR of 8.65%. Browse 77 ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):